XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2021
Schedule of Recognized Stock-Based Compensation Expense

During the three months ended March 31, 2021 and March 31, 2020 the Company recognized stock-based compensation expense as follows:

 

    For the Three Months Ended March 31,  
    2021     2020  
Subscriber related   $ 14     $ -  
Sales and marketing     713       -  
Technology and development     2,070       -  
General and administrative     6,577       9,061  
    $ 9,374     $ 9,061  
Schedule of Stock Options Assumptions

The following was used in determining the fair value of stock options granted during the three months ended March 31, 2021 and 2020:

 

    For the Three Months Ended March 31,  
    2021     2020  
Dividend yield     0 %     0 %
Expected price volatility     44.85 %     52.28 %
Risk-free interest rate     0.73 %     1.49 %
Expected term (years)     6.1       2.5  
Schedule of Stock Option Activity

A summary of stock option activity for the three months ended March 31, 2021 is as follows (in thousands, except share and per share amounts):

 

    Number of Shares     Weighted Average
Exercise Price		     Total Intrinsic Value     Weighted Average Remaining Contractual Life
(in years)		  
Outstanding as of December 31, 2020     13,450,565     $ 5.45     $ 303,036       8.1  
Granted     62,599     $ 21.14                  
Exercised     (1,011,954 )   $ 0.76                  
Forfeited or expired     (290,724 )   $ 4.15                  
Outstanding as of March 31, 2021     12,210,486     $ 5.95     $ 197,917       8.0  
                                 
Options vested and exercisable as of March 31, 2021     5,119,688     $ 3.18     $ 96,994       3.8  
Schedule of Restricted Stock Unit Activity

A summary of the Company’s restricted stock unit activity during the three months ended March 31, 2021 is as follows:

 

    Number of Shares     Weighted Average Grant-Date
Fair Value		  
Unvested at December 31, 2020     85,000     $ 25.26  
Granted     1,046,543     $ 33.02  
Unvested at March 31, 2021     1,131,543     $ 32.44  
Summary of Outstanding Warrants Activity

A summary of the Company’s outstanding warrants as of March 31, 2021 are presented below (in thousands, except share and per share amounts):

 

    Number of Warrants     Weighted Average
Exercise Price		     Total Intrinsic Value     Weighted Average Remaining Contractual Life
(in years)		  
Outstanding as of December 31, 2020     2,535,528     $ 8.22     $ 50,560       1.0  
Exercised     (713,257 )   $ 8.83     $ -       -  
Outstanding as of March 31, 2021     1,822,271     $ 7.98     $ 26,171       0.7  
                                 
Warrants exercisable as of March 31, 2021     1,822,271     $ 7.98     $ 26,171       0.7  
Market and Service Condition Based Options [Member]  
Schedule of Stock Option Activity

A summary of activity under the Plan for market and service-based stock options for the three months ended March 31, 2021 is as follows (in thousands, except share and per share amounts):

 

    Number of Shares     Weighted Average
Exercise Price		     Total Intrinsic Value     Weighted Average Remaining Contractual Life
(in years)		  
Outstanding as of December 31, 2020     3,078,297     $ 9.69     $ 56,351       6.3  
Outstanding as of March 31, 2021     3,078,297     $ 9.69     $ 38,250       6.1  
                                 
Options vested and exercisable as of March 31, 2021     3,078,297     $ 9.69     $ 38,250       6.1